Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0013841017
Tue, 06.09.2022
Lonza Group AG
Lonza Group AG
/ Key word(s): Partnership
Lonza and Touchlight collaborate on end-to-end mRNA offering
06.09.2022 / 07:00 CET/CEST
Collaboration expands Lonza’s end-to-end offering for mRNA manufacturing with additional, differentiated source of DNA raw material, Touchlight’s doggybone DNA (dbDNATM)
Touchlight provides synthetic [ … ]
Fri, 22.07.2022
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
In H1 2022, Lonza delivers CHF 3 billion sales and 16.8%1 CER sales growth
CHF 987 million CORE EBITDA resulted in a margin of 33.1%
H1 2022 CAPEX reached 28.2% of sales as Lonza continues to execute planned investments
Group Outlook 2022 confirmed at low to mid-teens CER sales growth and CORE EBITDA m [ … ]
Fri, 22.07.2022
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
In H1 2022, Lonza delivers CHF 3 billion sales and 16.8%1 CER sales growth
CHF 987 million CORE EBITDA resulted in a margin of 33.1%
H1 2022 CAPEX reached 28.2% of sales as Lonza continues to execute planned investments
Group Outlook 2022 confirmed at low to mid-teens CER sales growth and CORE EBITDA m [ … ]
Fri, 01.07.2022
Lonza Group AG
Lonza Group AG
/ Key word(s): Personnel
Maria Soler Nunez appointed as Head, Group Operations
01.07.2022 / 08:00
Lonza appoints Maria Soler Nunez as Head, Group Operations
Maria joins Lonza from Novartis where she has led the quality organization since 2020
Maria will commence her tenure with Lonza Group on 1 August 2022, s [ … ]
Fri, 01.07.2022
Lonza Group AG
Lonza Group AG
/ Key word(s): Personnel
Maria Soler Nunez appointed as Head, Group Operations
01.07.2022 / 08:00
Lonza appoints Maria Soler Nunez as Head, Group Operations
Maria joins Lonza from Novartis where she has led the quality organization since 2020
Maria will commence her tenure with Lonza Group on 1 August 2022, s [ … ]
Fri, 01.07.2022
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Lonza to build a new large-scale, commercial drug product fill and finish facility to support customers across the entire product life cycle
Lonza will invest approximately CHF 500 million in the facility, fulfilling its strategic commitment to establish a commercial fill and finish offering that comp [ … ]
Fri, 01.07.2022
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Lonza to build a new large-scale, commercial drug product fill and finish facility to support customers across the entire product life cycle
Lonza will invest approximately CHF 500 million in the facility, fulfilling its strategic commitment to establish a commercial fill and finish offering that comp [ … ]
Wed, 26.01.2022
Lonza Group AG
Ad Hoc Release Pursuant to Art. 53 Listing Rules
Lonza delivers CHF 5.4 billion sales and 20% CER1 sales growth
CHF 1.7 billion CORE EBITDA resulted in a margin of 30.8%
2021 CAPEX reached 24% of sales, supporting long-term plan to deliver attractive margins through de-risked growth investments
Continuing focus on operational excellence and e [ … ]
Tue, 12.10.2021
Lonza Group AG
Ad Hoc News Release Pursuant to Art. 53 Listing Rules
At its Capital Markets Day, Lonza outlined strategic priorities and innovation highlights with a clear focus on sustainable value creation
Accelerated, de-risked, long-term investment program will drive sustainable business growth
2021 CAPEX anticipated at around 25% of sales, and remain eleva [ … ]
Thu, 26.08.2021
Lonza Group AG
Ad Hoc Release Pursuant to Art. 53 Listing Rules
Lonza appoints Philippe Deecke as CFO and member of the Lonza Group Executive Committee
Philippe brings a wealth of experience from a 30-year career, which includes senior leadership roles in Novartis finance and time working as a McKinsey consultant
He will commence his tenure with Lonza Group on [ … ]